Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,405.20
(
-2.38%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
108.44
(
0.18%
)
Bitcoin
66,707.01
(
1.14%
)
News Focus
News Focus
Post# of 257302
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

faxedreceipts

Send PM Follow Ignore
Followers 49
Posts 3878
Boards Moderated 0
Alias Born 09/14/2007

faxedreceipts

Re: DewDiligence post# 173645

Sunday, 12/07/2014 8:50:37 PM

Sunday, December 07, 2014 8:50:37 PM

Post# of 257302
The achilles heel with the ABBV treatment is that Norvir has to be used to to achieve high clinical results, much less so with HARVONI. Checkmate HARVONI. The competion to Harvoni is a niche player. That's the kiss of death for ABBV.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today